Janus kinases in inflammatory bowel disease: Four kinases for multiple purposes

Pharmacological Reports

Volumn 68, Issue 4, 2016, Pages 789-796

  Galien, René ^a  

^a Parc Biocitech   (France)

Author keywords

Cytokine; IBD; JAK; Treatment

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 9; JANUS KINASE INHIBITOR; CYTOKINE; JANUS KINASE;

ANTIINFLAMMATORY ACTIVITY; HOMEOSTASIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATORY BOWEL DISEASES; JANUS KINASES;

EID: 84965050669     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2016.04.001     Document Type: Review

References (122)

1. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
2. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu Rev Immunol 28 2010 573 621
3. C. Abraham, and J.H. Cho Inflammatory bowel disease N Engl J Med 361 2009 2066 2078
4. S. Danese, and C. Fiocchi Ulcerative colitis N Engl J Med 365 18 2011 1713 1725
5. M.F. Neurath Cytokines in inflammatory bowel disease Nat Rev Immunol 14 5 2014 329 342
6. J.J. O'Shea, S.M. Holland, and L.M. Staudt JAKs and STATs in immunity, immunodeficiency, and cancer N Engl J Med 368 2 2013 161 170
7. S.J. Sohn, K. Barrett, A. Van Abbema, C. Chang, P.B. Kohli, H. Kanda, and et al. A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors J Immunol 191 5 2013 2205 2216
8. T1 Hosokawa, K. Kusugami, K. Ina, T. Ando, M. Shinoda, A. Imada, and et al. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease J Gastroenterol Hepatol 14 1999 987 996
9. S. Matsumoto, T. Hara, K. Mitsuyama, M. Yamamoto, O. Tsuruta, M. Sata, and et al. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model J Immunol 184 3 2010 1543 1551
10. V. Gross, T. Andus, I. Caesar, M. Roth, and J. Schölmerich Evidence for continuous stimulation of interleukin-6 production in Crohn's disease Gastroenterology 102 1992 514 519
11. J.S. Hyams, J.E. Fitzgerald, W.R. Treem, N. Wyzga, and D.L. Kreutzer Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease Gastroenterology 104 1993 1285 1292
12. H.C. Reinecker, M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R.P. MacDermott, and et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease Clin Exp Immunol 94 1993 174 181
13. K. Kusugami, A. Fukatsu, M. Tanimoto, M. Shinoda, J. Haruta, A. Kuroiwa, and et al. Elevation of interleukin-6 in inflammatory bowel disease is macrophage and epithelial cell-dependent Dig Dis Sci 40 1995 949 959
14. R. Atreya, J. Mudter, S. Finotto, J. Müllberg, T. Jostock, S. Wirtz, and et al. Blockade of interleukin 6 trans-signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo Nat Med 6 2000 583 588
15. D. Yen, J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, B. McKenzie, and et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 J Clin Invest 116 2006 1310 1316
16. R1 Atreya, and M.F. Neurath Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer Clin Rev Allergy Immunol 28 3 2005 187 196
17. M. Yamamoto, K. Yoshizaki, T. Kishimoto, and H. Ito IL-6 is required for the development of Th1 cell-mediated murine colitis J Immunol 164 9 2000 4878 4882
18. A. Kimura, and T. Kishimoto IL-6: regulator of Treg/Th17 balance Eur J Immunol 40 2010 1830 1835
19. + regulatory T cells J Immunol 186 2011 32 40
20. L. Zhou, I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, and et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways Nat Immunol 8 9 2007 967 974
21. L.E. Sander, F. Obermeier, U. Dierssen, D.C. Kroy, A.K. Singh, U. Seidler, and et al. Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activation J Immunol 181 5 2008 3586 3594
22. R. Al-Sadi, D. Ye, M. Boivin, S. Guo, M. Hashimi, L. Ereifej, and et al. Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene PLOS ONE 9 3 2014 e85345 10.1371/journal.pone.0085345
23. S.M. Dann, M.E. Spehlmann, D.C. Hammond, M. Iimura, K. Hase, L.J. Choi, and et al. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens J Immunol 180 10 2008 6816 6826
24. K.A. Kuhn, N.A. Manieri, T.C. Liu, and T.S. Stappenbeck IL-6 stimulates intestinal epithelial proliferation and repair after injury PLOS ONE 9 12 2014 e114195 10.1371/journal.pone.0114195
25. S. Grivennikov, E. Karin, J. Terzic, D. Mucida, G.Y. Yu, S. Vallabhapurapu, and et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer Cancer Cell 15 2 2009 103 113
26. H. Ito, M. Takazoe, Y. Fukuda, T. Hibi, K. Kusugami, A. Andoh, and et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease Gastroenterology 126 4 2004 989 996
27. G. Trinchieri, S. Pflanz, and R.A. Kastelein The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses Immunity 19 2003 641 644
28. R.A. Kastelein, C.A. Hunter, and D.J. Cua Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation Annu Rev Immunol 25 2007 221 242
29. S.N. Harbour, C.L. Maynard, C.L. Zindl, T.R. Schoeb, and C.T. Weaver Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis Proc Natl Acad Sci U S A 112 22 2015 7061 7066
30. C.W. Lees, J.C. Barrett, M. Parkes, and J. Satsangi New IBD genetics: common pathways with other diseases Gut 60 12 2011 1739 1753
31. W.J. Sandborn, C. Gasink, L.L. Gao, M.A. Blank, J. Johanns, C. Guzzo, and et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease N Engl J Med 367 16 2012 1519 1528
32. C.M. Bacon, D.W. McVicar, J.R. Ortaldo, R.C. Rees, J.J. O'Shea, and J.A. Johnston Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12 J Exp Med 181 1 1995 399 404
33. C. Parham, M. Chirica, J. Timans, E. Vaisberg, M. Travis, J. Cheung, and et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R J Immunol 168 11 2002 5699 5708
34. M. Karaghiosoff, H. Neubauer, C. Lassnig, P. Kovarik, H. Schindler, H. Pircher, and et al. Partial impairment of cytokine responses in Tyk2-deficient mice Immunity 13 4 2000 549 560
35. N. Tokumasa, A. Suto, S. Kagami, S. Furuta, K. Hirose, N. Watanabe, and et al. Expression of Tyk2 in dendritic cells is required for IL-12, IL-23, and IFN-gamma production and the induction of Th1 cell differentiation Blood 110 2 2007 553 560
36. Y. Minegishi, M. Saito, T. Morio, K. Watanabe, K. Agematsu, S. Tsuchiya, and et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity Immunity 25 5 2006 745 755
37. D. Diogo, L. Bastarache, K.P. Liao, R.R. Graham, R.S. Fulton, J.D. Greenberg, and et al. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits PLOS ONE 10 4 2015
38. M. Ishizaki, T. Akimoto, R. Muromoto, M. Yokoyama, Y. Ohshiro, Y. Sekine, and et al. Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo J Immunol 187 1 2011 181 189
39. E. Hainzl, S. Stockinger, I. Rauch, S. Heider, D. Berry, C. Lassnig, and et al. Intestinal epithelial cell tyrosine kinase 2 transduces IL-22 signals to protect from acute colitis J Immunol 195 10 2015 5011 5024
40. R. Nakamura, K. Shibata, H. Yamada, K. Shimoda, K. Nakayama, and Y. Yoshikai Tyk2-signaling plays an important role in host defense against Escherichia coli through IL-23-induced IL-17 production by γδ T cells J Immunol 181 3 2008 2071 2075
41. N. Sugimoto, M. Nakahira, H.J. Ahn, M. Micallef, T. Hamaoka, M. Kurimoto, and et al. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18 Eur J Immunol 33 1 2003 243 251
42. J.B. Demoulin, C. Uyttenhove, E. Van Roost, B. DeLestré, D. Donckers, J. Van Snick, and et al. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9 Mol Cell Biol 16 9 1996 4710 4716
43. J.H. Bauer, K.D. Liu, Y. You, S.Y. Lai, and M.A. Goldsmith Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis J Biol Chem 273 15 1998 9255 9260
44. C. Haan, C. Rolvering, F. Raulf, M. Kapp, P. Drückes, G. Thoma, and et al. Jak1 has a dominant role over Jak3 in signal transduction through (c-containing cytokine receptors Chem Biol 18 3 2011 314 323
45. E.R. Goedken, M.A. Argiriadi, D.L. Banach, B.A. Fiamengo, S.E. Foley, K.E. Frank, and et al. Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol J Biol Chem 290 8 2015 4573 4589
46. N. Nalleweg, M.T. Chiriac, E. Podstawa, C. Lehmann, T.T. Rau, R. Atreya, and et al. IL-9 and its receptor are predominantly involved in the pathogenesis of UC Gut 64 5 2014 743 755
47. C. Defendenti, P. Sarzi-Puttini, S. Saibeni, S. Bollani, S. Bruno, P.L. Almasio, and et al. Significance of serum Il-9 levels in inflammatory bowel disease Int J Immunopathol Pharmacol 28 4 2015 569 575
48. K. Gerlach, Y. Hwang, A. Nikolaev, R. Atreya, H. Dornhoff, S. Steiner, and et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells Nat Immunol 15 7 2014 676 686
49. (-) effector T cells Nat Immunol 9 12 2008 1347 1355
50. A. Yuan, H. Yang, H. Qi, J. Cui, W. Hua, C. Li, and et al. IL-9 antibody injection suppresses the inflammation in colitis mice Biochem Biophys Res Commun 468 4 2015 921 926
51. D.S. Shouval, J. Ouahed, A. Biswas, J.A. Goettel, B.H. Horwitz, C. Klein, and et al. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans Adv Immunol 122 2014 177 210
52. J.K. Riley, K. Takeda, S. Akira, and R.D. Schreiber Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action J Biol Chem 274 23 1999 16513 16521
53. S.J. Rodig, M.A. Meraz, J.M. White, P.A. Lampe, J.K. Riley, C.D. Arthur, and et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses Cell 93 3 1998 373 383
54. Z. Li, M. Gakovic, J. Ragimbeau, M.L. Eloranta, L. Rönnblom, F. Michel, and et al. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent J Immunol 190 5 2013 2335 2344
55. S.R. Hofmann, A. Rösen-Wolff, G.C. Tsokos, and C.M. Hedrich Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury Clin Immunol 143 2 2012 116 127
56. Y.P. Rubtsov, J.P. Rasmussen, E.Y. Chi, J. Fontenot, L. Castelli, X. Ye, and et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces Immunity 28 4 2008 546 558 10.1016/j.immuni.2008.02.017
57. R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, and W. Müller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 2 1993 263 274
58. F. Powrie, R. Correa-Oliveira, S. Mauze, and R.L. Coffman Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity J Exp Med 179 2 1994 589 600
59. H. De Winter, D. Elewaut, O. Turovskaya, M. Huflejt, C. Shimeld, A. Hagenbaugh, and et al. Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice Gastroenterology 122 7 2002 1829 1841
60. L. Steidler, W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, and et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 Science 289 5483 2000 1352 1355
61. D.S. Shouval, A. Biswas, J.A. Goettel, K. McCann, E. Conaway, N.S. Redhu, and et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function Immunity 40 5 2014 706 719
62. F.E. Buruiana, I. Solà, and P. Alonso-Coello Recombinant human interleukin 10 for induction of remission in Crohn's disease Cochrane Database Syst Rev 10 11 2010 CD005109
63. D. Lejeune, L. Dumoutier, S. Constantinescu, W. Kruijer, J.J. Schuringa, and J.C. Renauld Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10 J Biol Chem 277 37 2002 33676 33682
64. N.J. Logsdon, B.C. Jones, K. Josephson, J. Cook, and M.R. Walter Comparison of interleukin-22 and interleukin-10 soluble receptor complexes J Interferon Cytokine Res 22 2002 1099 1112
65. K. Wolk, S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat IL-22 increases the innate immunity of tissues Immunity 21 2 2004 241 254
66. L. Dumoutier, D. Lejeune, S. Hor, H. Fickenscher, and J.C. Renauld Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3 Biochem J 370 Pt 2 2003 391 396
67. S. Brand, F. Beigel, T. Olszak, K. Zitzmann, S.T. Eichhorst, J.M. Otte, and et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration Am J Physiol Gastrointest Liver Physiol 290 4 2006 G827 G838
68. K. Sugimoto, A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, A.K. Bhan, and et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis J Clin Invest 118 2 2008 534 544
69. G. Pickert, C. Neufert, M. Leppkes, Y. Zheng, N. Wittkopf, M. Warntjen, and et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing J Exp Med 206 7 2009 1465 1472
70. J.M. Leung, M. Davenport, M.J. Wolff, K.E. Wiens, W.M. Abidi, M.A. Poles, and et al. IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue Mucosal Immunol 7 1 2014 124 133
71. C.A. Lindemans, M. Calafiore, A.M. Mertelsmann, M.H. O'Connor, J.A. Dudakov, R.R. Jenq, and et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration Nature 528 7583 2015 560 564
72. X. Guo, J. Qiu, T. Tu, X. Yang, L. Deng, R.A. Anders, and et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection Immunity 40 1 2014 25 39
73. S. Kirchberger, D.J. Royston, O. Boulard, E. Thornton, F. Franchini, R.L. Szabady, and et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model J Exp Med 210 5 2013 917 931
74. J.A. Hamilton GM-CSF in inflammation and autoimmunity Trends Immunol 23 2002 403 408
75. T.R. Hercus, D. Thomas, M.A. Guthridge, P.G. Ekert, J. King-Scott, M.W. Parker, and et al. The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease Blood 114 7 2009 1289 1298
76. S. Watanabe, T. Itoh, and K.I. Arai JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells J Biol Chem 271 1996 12681 12686
77. F.W. Quelle, N. Sato, B.A. Witthuhn, R.C. Inhorn, M. Eder, A. Miyajima, and et al. JAK2 associates with the bc chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region Mol Cell Biol 14 1994 4335 4341
78. I. Sakai, and A.S. Kraft The kinase domain of Jak2 mediates induction of Bcl-2 and delays cell death in hematopoietic cells J Biol Chem 272 1997 12350 12358
79. S.E. Doyle, and J.C. Gasson Characterization of the role of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit in the activation of JAK2 and STAT5 Blood 92 3 1998 867 876
80. A.L-F. Mui, H. Wakao, A-M. O'Farrell, N. Harada, and A. Miyajima Interleukin-3, granulocyte-macrophage colony-stimulating factor andinterleukin-5 transduce signals through two STAT5 homologs EMBO J 14 1995 1166 1175
81. M.F. Brizzi, M.G. Aronica, A. Rosso, G.P. Bagnara, Y. Yarden, and L. Pegoraro Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes J Biol Chem 271 7 1996 3562 3567
82. Y. Xu, N.H. Hunt, and S. Bao The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation Cell Res 18 12 2008 1220 1229
83. S.K. Sainathan, E.M. Hanna, Q. Gong, K.S. Bishnupuri, Q. Luo, M. Colonna, and et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis Inflamm Bowel Dis 14 1 2008 88 99
84. E. Bernasconi, L. Favre, M.H. Maillard, D. Bachmann, C. Pythoud, H. Bouzourene, and et al. Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing Inflamm Bowel Dis 16 3 2010 428 441
85. X. Han, K. Uchida, I. Jurickova, D. Koch, T. Willson, C. Samson, and et al. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease Gastroenterology 136 4 2009 1261 1271
86. G. Gathungu, M.O. Kim, J.P. Ferguson, Y. Sharma, W. Zhang, S.M. Ng, and et al. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease Inflamm Bowel Dis 19 8 2013 1671 1680
87. J. Däbritz, E. Bonkowski, C. Chalk, B.C. Trapnell, J. Langhorst, L.A. Denson, and et al. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease Am J Gastroenterol 108 12 2013 1901 1910
88. J. Däbritz, T. Weinhage, G. Varga, T. Wirth, K. Walscheid, A. Brockhausen, and et al. Reprogramming of monocytes by GM-CSF contributes to regulatory immune functions during intestinal inflammation J Immunol 194 5 2015 2424 2438
89. S. Danese New therapies for inflammatory bowel disease: from the bench to the bedside Gut 61 2012 918 932
90. S.Y. Zhang, S. Boisson-Dupuis, A. Chapgier, K. Yang, J. Bustamante, A. Puel, and et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-lambda in host defense Immunol Rev 226 2008 29 40
91. S. Pestka, S.V. Kotenko, G. Muthukumaran, L.S. Izotova, J.R. Cook, and G. Garotta The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor Cytokine Growth Factor Rev 8 3 1997 189 206
92. M. Müller, J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, and et al. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction Nature 366 1993 129 166
93. D. Watling, D. Guschin, M. Müller, O. Silvennoinen, B.A. Witthuhn, F.W. Quelle, and et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway Nature 366 6451 1993 166 170
94. S.V. Kotenko, L.S. Izotova, B.P. Pollack, T.M. Mariano, R.J. Donnelly, G. Muthukumaran, and et al. Interaction between the components of the interferon gamma receptor complex J Biol Chem 270 36 1995 20915 20921
95. K. Igarashi, G. Garotta, L. Ozmen, A. Ziemiecki, A.F. Wilks, A.G. Harpur, and et al. Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor J Biol Chem 269 1994 14333 14336
96. J. Briscoe, N.C. Rogers, B.A. Witthuhn, D. Watling, A.G. Harpur, A.F. Wilks, and et al. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state EMBO J 15 4 1996 799 809
97. E. Keil, D. Finkenstädt, C. Wufka, M. Trilling, P. Liebfried, B. Strobl, and et al. Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation-loop mutation Blood 123 4 2014 520 529
98. X. Hu, C. Herrero, W.P. Li, T.T. Antoniv, E. Falck-Pedersen, A.E. Koch, and et al. Sensitization of IFN-γ Jak-STAT signaling during macrophage activation Nat Immunol 3 2002 859 866
99. D.K. Dalton, S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart Multiple defects of immune cell function in mice with disrupted interferon-γ genes Science 259 1993 1739 1742
100. + T cell lineage differentiation Immunity 30 2009 646 655
101. X. Hu, and L.B. Ivashkiv Cross-regulation of signaling pathways by interferon-γ: implications for immune responses and autoimmune diseases Immunity 31 2009 539 550
102. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1996 1261 1270
103. + T cells Immunity 1 1994 553 562
104. W. Hans, J. Schölmerich, V. Gross, and W. Falk Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice Eur Cytokine Netw 11 2000 67 74
105. R. Ito, M. Shin-Ya, T. Kishida, A. Urano, R. Takada, J. Sakagami, and et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice Clin Exp Immunol 146 2006 330 338
106. P. Nava, S. Koch, M.G. Laukoetter, W.Y. Lee, K. Kolegraff, C.T. Capaldo, and et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways Immunity 32 3 2010 392 402
107. L.E. Glover, K. Irizarry, M. Scully, E.L. Campbell, B.E. Bowers, C.M. Aherne, and et al. IFN-γ attenuates hypoxia-inducible factor (HIF) activity in intestinal epithelial cells through transcriptional repression of HIF-1β J Immunol 186 3 2011 1790 1798
108. S.Z. Sheikh, K. Matsuoka, T. Kobayashi, F. Li, T. Rubinas, and S.E. Plevy IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis J Immunol 184 8 2010 4069 4073
109. W. Reinisch, W. de Villiers, L. Bene, L. Simon, I. Rácz, S. Katz, and et al. Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study Inflamm Bowel Dis 16 2 2010 233 242
110. B.A. Witthuhn, F.W. Quelle, O. Silvennoinen, T. Yi, B. Tang, O. Miura, and et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin Cell 74 2 1993 227 236
111. S. Gilbert, R. Zhang, L. Denson, R. Moriggl, K. Steinbrecher, N. Shroyer, and et al. Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation EMBO Mol Med 4 2 2012 109 124
112. S. Gilbert, H. Nivarthi, C.N. Mayhew, Y.H. Lo, T.K. Noah, J. Vallance, and et al. Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration Stem Cell Reports 4 2 2015 209 225
113. M.G. Works, F. Yin, C.C. Yin, Y. Yiu, K. Shew, T.T. Tran, and et al. Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis J Immunol 193 7 2014 3278 3287
114. W. Miao, C. Masse, J. Greenwood, R. Kapeller, Westlin.W. Potent, and Selective Tyk2 Inhibitors Block Th1- and Th17-mediated immune responses and reduce disease progression in rodent models of delayed-type hypersensitivity and psoriasis Arthritis Rheumatol 67 Suppl. 10 2015 [abstract]
115. T. Yogo, H. Nagamiya, M. Seto, S. Sasaki, H. Shih-Chung, Y. Ohba, and et al. Structure-based design and synthesis of 3-amino-1,5-dihydro-4h-pyrazolopyridin-4-one derivatives as tyrosine kinase 2 inhibitors J Med Chem 59 2 2016 733 749
116. W.J. Sandborn, S. Ghosh, J. Panes, I. Vranic, C. Su, S. Rousell, and et al. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis N Engl J Med 367 7 2012 616 624
117. http://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-positive-top-line-results-from-two-phase-3-trials-of-oral-tofacitinib-in-adults-with-moderate-to-severe-ulcerative-colitis; 2015.
118. W.J. Sandborn, S. Ghosh, J. Panes, I. Vranic, W. Wang, W. Niezychowski, and et al. A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease Clin Gastroenterol Hepatol 12 9 2014 1485 1493
119. J. Mishra, R.K. Verma, G. Alpini, F. Meng, and N. Kumar Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis J Biol Chem 288 44 2013 31795 31806
120. L. Van Rompaey, R. Galien, E.M. van der Aar, P. Clement-Lacroix, L. Nelles, B. Smets, and et al. Preclinical characterization of GLPG0634, a selective inhibitor of JAK1, for the treatment of inflammatory diseases J Immunol 191 7 2013 3568 3577
121. D. Merciris, C. Delachaume, V. De Vriendt, A.L. Boutet, L. Perret, M.C. Ceccotti, and et al. GLPG0634, the first selective JAK1 inhibitor, shows strong activity in the mouse DSS-colitis model J Crohns Colitis 8 Suppl. 1 2014 S92
122. http://www.glpg.com/docs/view/5665ff4ee8e93-en; 2015.